Clinical Trial Update: 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating a 4-valent HPV vaccine for treating recurrent respiratory papillomatosis in children, with current status listed as UNKNO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• 4-valent HPV vaccine (HPV quadrivalent vaccine)

Snippet

Sponsor: National Institute of Child Health, Hungary | Conditions: Recurrent Respiratory Papillomatosis | Phase 3 | Status: UNKNOWN